OpenEvidence Embeds ASCO Guidelines into Oncology AI Model

Event summary

  • OpenEvidence integrated ASCO Guidelines, figures, and flowcharts into its specialty oncology model on May 27, 2026.
  • ASCO licensed its guidelines to OpenEvidence to enhance clinical decision-making support.
  • The integration includes direct links to ASCO source documents and peer-reviewed evidence.
  • Travis Zack, MD PhD, OpenEvidence's Chief Medical Officer, led the project to train models on ASCO materials.

The big picture

This integration positions OpenEvidence as a leader in AI-driven clinical decision support, particularly in oncology. By embedding ASCO's authoritative guidelines, the platform gains a competitive edge in providing evidence-based recommendations. The move aligns with broader industry trends toward AI augmentation of medical expertise, potentially setting a new standard for specialty-specific medical knowledge platforms.

What we're watching

Adoption Pace
How quickly U.S. oncologists integrate ASCO-enhanced OpenEvidence into clinical workflows.
Model Accuracy
Whether OpenEvidence maintains high accuracy in interpreting ASCO guidelines and figures.
Competitive Response
How rival medical AI platforms react to this ASCO partnership.